カテゴリー： 世界, 医療/バイオ, LP Information

世界の前立腺肥大症（BPH）治療装置市場予測 2023年-2029年

【英語タイトル】Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Growth 2023-2029

LP Informationが出版した調査資料（LP23MY4158）・商品コード：LP23MY4158
・発行会社（調査会社）：LP Information
・発行日：2023年5月（※2025年版があります。お問い合わせください。）
・ページ数：127
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥527,040見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥790,560見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,054,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の前立腺肥大症（BPH）治療装置市場」は、過去の販売実績から2022年の世界の前立腺肥大症（BPH）治療装置の総販売量を検討し、2023年から2029年の予測される前立腺肥大症（BPH）治療装置の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の前立腺肥大症（BPH）治療装置の市場規模を掲載し、XXX百万米ドル規模の世界の前立腺肥大症（BPH）治療装置市場の詳細な分析を提供します。本インサイトレポートは、世界の前立腺肥大症（BPH）治療装置業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の前立腺肥大症（BPH）治療装置市場における各社の独自のポジションをより深く理解するために、前立腺肥大症（BPH）治療装置製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の前立腺肥大症（BPH）治療装置市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。前立腺肥大症（BPH）治療装置の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。前立腺肥大症（BPH）治療装置の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。前立腺肥大症（BPH）治療装置のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

前立腺肥大症（BPH）治療装置の世界主要メーカーとしては、Advin Urology、 Biolitec、 Boston Scientific Corporation、 CONMED、 Convergent Laser Technologies、 CoreTherm Medical, Inc. (ProstaLund)、 HistoSonics, Inc.、 JenaSurgical GmbH、 KARL STORZ、 LISA Laser Products GmbH、 Lumenis Ltd.、 Medifocus, Inc.、 Endo International、 Medtronic、 Siemens、 Olympus、 Urologix、 NeoTract、 Urotech、 Baxter Internationalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の前立腺肥大症（BPH）治療装置市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では前立腺肥大症（BPH）治療装置市場をセグメンテーションし、種類別 (外科治療、低侵襲治療、レーザー治療、その他)、用途別 (不妊クリニック、病院、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：外科治療、低侵襲治療、レーザー治療、その他

・用途別区分：不妊クリニック、病院、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の前立腺肥大症（BPH）治療装置市場の10年間の市場状況・展望は？
・世界および地域別に見た前立腺肥大症（BPH）治療装置市場成長の要因は何か？
・前立腺肥大症（BPH）治療装置の市場機会はエンドマーケットの規模によってどのように変化するのか？
・前立腺肥大症（BPH）治療装置のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：前立腺肥大症（BPH）治療装置の年間販売量2018-2029、地域別現状・将来分析
・前立腺肥大症（BPH）治療装置の種類別セグメント：外科治療、低侵襲治療、レーザー治療、その他
・前立腺肥大症（BPH）治療装置の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・前立腺肥大症（BPH）治療装置の用途別セグメント：不妊クリニック、病院、その他
・前立腺肥大症（BPH）治療装置の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の前立腺肥大症（BPH）治療装置市場
・企業別のグローバル前立腺肥大症（BPH）治療装置市場データ：2018-2023年の年間販売量、市場シェア
・企業別の前立腺肥大症（BPH）治療装置の年間売上：2018-2023年の売上、市場シェア
・企業別の前立腺肥大症（BPH）治療装置販売価格
・主要企業の前立腺肥大症（BPH）治療装置生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

前立腺肥大症（BPH）治療装置の地域別レビュー
・地域別の前立腺肥大症（BPH）治療装置市場規模2018-2023：年間販売量、売上
・主要国別の前立腺肥大症（BPH）治療装置市場規模2018-2023：年間販売量、売上
・南北アメリカの前立腺肥大症（BPH）治療装置販売の成長
・アジア太平洋の前立腺肥大症（BPH）治療装置販売の成長
・ヨーロッパの前立腺肥大症（BPH）治療装置販売の成長
・中東・アフリカの前立腺肥大症（BPH）治療装置販売の成長

南北アメリカ市場
・南北アメリカの国別の前立腺肥大症（BPH）治療装置販売量、売上（2018-2023）
・南北アメリカの前立腺肥大症（BPH）治療装置の種類別販売量
・南北アメリカの前立腺肥大症（BPH）治療装置の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の前立腺肥大症（BPH）治療装置販売量、売上（2018-2023）
・アジア太平洋の前立腺肥大症（BPH）治療装置の種類別販売量
・アジア太平洋の前立腺肥大症（BPH）治療装置の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の前立腺肥大症（BPH）治療装置販売量、売上（2018-2023）
・ヨーロッパの前立腺肥大症（BPH）治療装置の種類別販売量
・ヨーロッパの前立腺肥大症（BPH）治療装置の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の前立腺肥大症（BPH）治療装置販売量、売上（2018-2023）
・中東・アフリカの前立腺肥大症（BPH）治療装置の種類別販売量
・中東・アフリカの前立腺肥大症（BPH）治療装置の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・前立腺肥大症（BPH）治療装置の製造コスト構造分析
・前立腺肥大症（BPH）治療装置の製造プロセス分析
・前立腺肥大症（BPH）治療装置の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・前立腺肥大症（BPH）治療装置の主要なグローバル販売業者
・前立腺肥大症（BPH）治療装置の主要なグローバル顧客

地域別の前立腺肥大症（BPH）治療装置市場予測レビュー
・地域別の前立腺肥大症（BPH）治療装置市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・前立腺肥大症（BPH）治療装置の種類別市場規模予測
・前立腺肥大症（BPH）治療装置の用途別市場規模予測

主要企業分析
Advin Urology、 Biolitec、 Boston Scientific Corporation、 CONMED、 Convergent Laser Technologies、 CoreTherm Medical, Inc. (ProstaLund)、 HistoSonics, Inc.、 JenaSurgical GmbH、 KARL STORZ、 LISA Laser Products GmbH、 Lumenis Ltd.、 Medifocus, Inc.、 Endo International、 Medtronic、 Siemens、 Olympus、 Urologix、 NeoTract、 Urotech、 Baxter International
・企業情報
・前立腺肥大症（BPH）治療装置製品
・前立腺肥大症（BPH）治療装置販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

LPI (LP Information)’ newest research report, the “Benign Prostatic Hyperplasia (BPH) Treatment Devices Industry Forecast” looks at past sales and reviews total world Benign Prostatic Hyperplasia (BPH) Treatment Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Benign Prostatic Hyperplasia (BPH) Treatment Devices sales for 2023 through 2029. With Benign Prostatic Hyperplasia (BPH) Treatment Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Benign Prostatic Hyperplasia (BPH) Treatment Devices industry.
This Insight Report provides a comprehensive analysis of the global Benign Prostatic Hyperplasia (BPH) Treatment Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Benign Prostatic Hyperplasia (BPH) Treatment Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Benign Prostatic Hyperplasia (BPH) Treatment Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Benign Prostatic Hyperplasia (BPH) Treatment Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Benign Prostatic Hyperplasia (BPH) Treatment Devices.
The global Benign Prostatic Hyperplasia (BPH) Treatment Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Benign Prostatic Hyperplasia (BPH) Treatment Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Benign Prostatic Hyperplasia (BPH) Treatment Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Benign Prostatic Hyperplasia (BPH) Treatment Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Benign Prostatic Hyperplasia (BPH) Treatment Devices players cover Advin Urology, Biolitec, Boston Scientific Corporation, CONMED, Convergent Laser Technologies, CoreTherm Medical, Inc. (ProstaLund), HistoSonics, Inc., JenaSurgical GmbH and KARL STORZ, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Benign Prostatic Hyperplasia (BPH) Treatment Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Surgical Treatment
Minimally Invasive Treatment
Laser Treatment
Other
Segmentation by application
Fertility Clinics
Hospitals
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Advin Urology
Biolitec
Boston Scientific Corporation
CONMED
Convergent Laser Technologies
CoreTherm Medical, Inc. (ProstaLund)
HistoSonics, Inc.
JenaSurgical GmbH
KARL STORZ
LISA Laser Products GmbH
Lumenis Ltd.
Medifocus, Inc.
Endo International
Medtronic
Siemens
Olympus
Urologix
NeoTract
Urotech
Baxter International
Key Questions Addressed in this Report
What is the 10-year outlook for the global Benign Prostatic Hyperplasia (BPH) Treatment Devices market?
What factors are driving Benign Prostatic Hyperplasia (BPH) Treatment Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Benign Prostatic Hyperplasia (BPH) Treatment Devices market opportunities vary by end market size?
How does Benign Prostatic Hyperplasia (BPH) Treatment Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Benign Prostatic Hyperplasia (BPH) Treatment Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Benign Prostatic Hyperplasia (BPH) Treatment Devices by Country/Region, 2018, 2022 & 2029
2.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Segment by Type
2.2.1 Surgical Treatment
2.2.2 Minimally Invasive Treatment
2.2.3 Laser Treatment
2.2.4 Other
2.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type
2.3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sale Price by Type (2018-2023)
2.4 Benign Prostatic Hyperplasia (BPH) Treatment Devices Segment by Application
2.4.1 Fertility Clinics
2.4.2 Hospitals
2.4.3 Others
2.5 Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application
2.5.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sale Price by Application (2018-2023)
3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices by Company
3.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Breakdown Data by Company
3.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Annual Sales by Company (2018-2023)
3.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Company (2018-2023)
3.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Company (2018-2023)
3.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Company (2018-2023)
3.3 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sale Price by Company
3.4 Key Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Location Distribution
3.4.2 Players Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Benign Prostatic Hyperplasia (BPH) Treatment Devices by Geographic Region
4.1 World Historic Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth
4.4 APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth
4.5 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth
4.6 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth
5 Americas
5.1 Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country
5.1.1 Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2018-2023)
5.1.2 Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2018-2023)
5.2 Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type
5.3 Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region
6.1.1 APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2018-2023)
6.1.2 APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Region (2018-2023)
6.2 APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type
6.3 APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices by Country
7.1.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2018-2023)
7.1.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2018-2023)
7.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type
7.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices by Country
8.1.1 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type
8.3 Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices
10.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices
10.4 Industry Chain Structure of Benign Prostatic Hyperplasia (BPH) Treatment Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Distributors
11.3 Benign Prostatic Hyperplasia (BPH) Treatment Devices Customer
12 World Forecast Review for Benign Prostatic Hyperplasia (BPH) Treatment Devices by Geographic Region
12.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size Forecast by Region
12.1.1 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecast by Region (2024-2029)
12.1.2 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecast by Type
12.7 Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Forecast by Application
13 Key Players Analysis
13.1 Advin Urology
13.1.1 Advin Urology Company Information
13.1.2 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
13.1.3 Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Advin Urology Main Business Overview
13.1.5 Advin Urology Latest Developments
13.2 Biolitec
13.2.1 Biolitec Company Information
13.2.2 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
13.2.3 Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Biolitec Main Business Overview
13.2.5 Biolitec Latest Developments
13.3 Boston Scientific Corporation
13.3.1 Boston Scientific Corporation Company Information
13.3.2 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
13.3.3 Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Boston Scientific Corporation Main Business Overview
13.3.5 Boston Scientific Corporation Latest Developments
13.4 CONMED
13.4.1 CONMED Company Information
13.4.2 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
13.4.3 CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 CONMED Main Business Overview
13.4.5 CONMED Latest Developments
13.5 Convergent Laser Technologies
13.5.1 Convergent Laser Technologies Company Information
13.5.2 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
13.5.3 Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Convergent Laser Technologies Main Business Overview
13.5.5 Convergent Laser Technologies Latest Developments
13.6 CoreTherm Medical, Inc. (ProstaLund)
13.6.1 CoreTherm Medical, Inc. (ProstaLund) Company Information
13.6.2 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
13.6.3 CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 CoreTherm Medical, Inc. (ProstaLund) Main Business Overview
13.6.5 CoreTherm Medical, Inc. (ProstaLund) Latest Developments
13.7 HistoSonics, Inc.
13.7.1 HistoSonics, Inc. Company Information
13.7.2 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
13.7.3 HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 HistoSonics, Inc. Main Business Overview
13.7.5 HistoSonics, Inc. Latest Developments
13.8 JenaSurgical GmbH
13.8.1 JenaSurgical GmbH Company Information
13.8.2 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
13.8.3 JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 JenaSurgical GmbH Main Business Overview
13.8.5 JenaSurgical GmbH Latest Developments
13.9 KARL STORZ
13.9.1 KARL STORZ Company Information
13.9.2 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
13.9.3 KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 KARL STORZ Main Business Overview
13.9.5 KARL STORZ Latest Developments
13.10 LISA Laser Products GmbH
13.10.1 LISA Laser Products GmbH Company Information
13.10.2 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
13.10.3 LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 LISA Laser Products GmbH Main Business Overview
13.10.5 LISA Laser Products GmbH Latest Developments
13.11 Lumenis Ltd.
13.11.1 Lumenis Ltd. Company Information
13.11.2 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
13.11.3 Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Lumenis Ltd. Main Business Overview
13.11.5 Lumenis Ltd. Latest Developments
13.12 Medifocus, Inc.
13.12.1 Medifocus, Inc. Company Information
13.12.2 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
13.12.3 Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Medifocus, Inc. Main Business Overview
13.12.5 Medifocus, Inc. Latest Developments
13.13 Endo International
13.13.1 Endo International Company Information
13.13.2 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
13.13.3 Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Endo International Main Business Overview
13.13.5 Endo International Latest Developments
13.14 Medtronic
13.14.1 Medtronic Company Information
13.14.2 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
13.14.3 Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Medtronic Main Business Overview
13.14.5 Medtronic Latest Developments
13.15 Siemens
13.15.1 Siemens Company Information
13.15.2 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
13.15.3 Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Siemens Main Business Overview
13.15.5 Siemens Latest Developments
13.16 Olympus
13.16.1 Olympus Company Information
13.16.2 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
13.16.3 Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Olympus Main Business Overview
13.16.5 Olympus Latest Developments
13.17 Urologix
13.17.1 Urologix Company Information
13.17.2 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
13.17.3 Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Urologix Main Business Overview
13.17.5 Urologix Latest Developments
13.18 NeoTract
13.18.1 NeoTract Company Information
13.18.2 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
13.18.3 NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 NeoTract Main Business Overview
13.18.5 NeoTract Latest Developments
13.19 Urotech
13.19.1 Urotech Company Information
13.19.2 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
13.19.3 Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Urotech Main Business Overview
13.19.5 Urotech Latest Developments
13.20 Baxter International
13.20.1 Baxter International Company Information
13.20.2 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
13.20.3 Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Baxter International Main Business Overview
13.20.5 Baxter International Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Benign Prostatic Hyperplasia (BPH) Treatment Devices Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Benign Prostatic Hyperplasia (BPH) Treatment Devices Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Surgical Treatment
Table 4. Major Players of Minimally Invasive Treatment
Table 5. Major Players of Laser Treatment
Table 6. Major Players of Other
Table 7. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2018-2023) & (K Units)
Table 8. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2018-2023)
Table 9. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Type (2018-2023) & ($ million)
Table 10. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Type (2018-2023)
Table 11. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2018-2023) & (K Units)
Table 13. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2018-2023)
Table 14. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Application (2018-2023)
Table 15. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Application (2018-2023)
Table 16. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Company (2018-2023) & (K Units)
Table 18. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Company (2018-2023)
Table 19. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Company (2018-2023)
Table 21. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Benign Prostatic Hyperplasia (BPH) Treatment Devices Producing Area Distribution and Sales Area
Table 23. Players Benign Prostatic Hyperplasia (BPH) Treatment Devices Products Offered
Table 24. Benign Prostatic Hyperplasia (BPH) Treatment Devices Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Geographic Region (2018-2023)
Table 29. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country/Region (2018-2023)
Table 33. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2018-2023) & (K Units)
Table 36. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country (2018-2023)
Table 37. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country (2018-2023)
Table 39. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2018-2023) & (K Units)
Table 40. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2018-2023) & (K Units)
Table 41. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2018-2023) & (K Units)
Table 42. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region (2018-2023)
Table 43. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Region (2018-2023)
Table 45. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2018-2023) & (K Units)
Table 46. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2018-2023) & (K Units)
Table 47. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2018-2023) & (K Units)
Table 48. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country (2018-2023)
Table 49. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country (2018-2023)
Table 51. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2018-2023) & (K Units)
Table 52. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Table 60. Key Market Challenges & Risks of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Table 61. Key Industry Trends of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Table 62. Benign Prostatic Hyperplasia (BPH) Treatment Devices Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Benign Prostatic Hyperplasia (BPH) Treatment Devices Distributors List
Table 65. Benign Prostatic Hyperplasia (BPH) Treatment Devices Customer List
Table 66. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Advin Urology Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 81. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
Table 82. Advin Urology Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Advin Urology Main Business
Table 84. Advin Urology Latest Developments
Table 85. Biolitec Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 86. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
Table 87. Biolitec Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Biolitec Main Business
Table 89. Biolitec Latest Developments
Table 90. Boston Scientific Corporation Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 91. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
Table 92. Boston Scientific Corporation Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Boston Scientific Corporation Main Business
Table 94. Boston Scientific Corporation Latest Developments
Table 95. CONMED Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 96. CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
Table 97. CONMED Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. CONMED Main Business
Table 99. CONMED Latest Developments
Table 100. Convergent Laser Technologies Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 101. Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
Table 102. Convergent Laser Technologies Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Convergent Laser Technologies Main Business
Table 104. Convergent Laser Technologies Latest Developments
Table 105. CoreTherm Medical, Inc. (ProstaLund) Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 106. CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
Table 107. CoreTherm Medical, Inc. (ProstaLund) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. CoreTherm Medical, Inc. (ProstaLund) Main Business
Table 109. CoreTherm Medical, Inc. (ProstaLund) Latest Developments
Table 110. HistoSonics, Inc. Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 111. HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
Table 112. HistoSonics, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. HistoSonics, Inc. Main Business
Table 114. HistoSonics, Inc. Latest Developments
Table 115. JenaSurgical GmbH Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 116. JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
Table 117. JenaSurgical GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. JenaSurgical GmbH Main Business
Table 119. JenaSurgical GmbH Latest Developments
Table 120. KARL STORZ Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 121. KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
Table 122. KARL STORZ Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. KARL STORZ Main Business
Table 124. KARL STORZ Latest Developments
Table 125. LISA Laser Products GmbH Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 126. LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
Table 127. LISA Laser Products GmbH Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. LISA Laser Products GmbH Main Business
Table 129. LISA Laser Products GmbH Latest Developments
Table 130. Lumenis Ltd. Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 131. Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
Table 132. Lumenis Ltd. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Lumenis Ltd. Main Business
Table 134. Lumenis Ltd. Latest Developments
Table 135. Medifocus, Inc. Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 136. Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
Table 137. Medifocus, Inc. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Medifocus, Inc. Main Business
Table 139. Medifocus, Inc. Latest Developments
Table 140. Endo International Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 141. Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
Table 142. Endo International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Endo International Main Business
Table 144. Endo International Latest Developments
Table 145. Medtronic Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 146. Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
Table 147. Medtronic Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Medtronic Main Business
Table 149. Medtronic Latest Developments
Table 150. Siemens Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 151. Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
Table 152. Siemens Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Siemens Main Business
Table 154. Siemens Latest Developments
Table 155. Olympus Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 156. Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
Table 157. Olympus Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Olympus Main Business
Table 159. Olympus Latest Developments
Table 160. Urologix Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 161. Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
Table 162. Urologix Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Urologix Main Business
Table 164. Urologix Latest Developments
Table 165. NeoTract Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 166. NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
Table 167. NeoTract Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 168. NeoTract Main Business
Table 169. NeoTract Latest Developments
Table 170. Urotech Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 171. Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
Table 172. Urotech Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 173. Urotech Main Business
Table 174. Urotech Latest Developments
Table 175. Baxter International Basic Information, Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 176. Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Portfolios and Specifications
Table 177. Baxter International Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 178. Baxter International Main Business
Table 179. Baxter International Latest Developments
List of Figures
Figure 1. Picture of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Figure 2. Benign Prostatic Hyperplasia (BPH) Treatment Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Surgical Treatment
Figure 10. Product Picture of Minimally Invasive Treatment
Figure 11. Product Picture of Laser Treatment
Figure 12. Product Picture of Other
Figure 13. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type in 2022
Figure 14. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Type (2018-2023)
Figure 15. Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumed in Fertility Clinics
Figure 16. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market: Fertility Clinics (2018-2023) & (K Units)
Figure 17. Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumed in Hospitals
Figure 18. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market: Hospitals (2018-2023) & (K Units)
Figure 19. Benign Prostatic Hyperplasia (BPH) Treatment Devices Consumed in Others
Figure 20. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Market: Others (2018-2023) & (K Units)
Figure 21. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2022)
Figure 22. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Application in 2022
Figure 23. Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market by Company in 2022 (K Units)
Figure 24. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Company in 2022
Figure 25. Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Company in 2022
Figure 27. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales 2018-2023 (K Units)
Figure 30. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue 2018-2023 ($ Millions)
Figure 31. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales 2018-2023 (K Units)
Figure 32. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue 2018-2023 ($ Millions)
Figure 33. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales 2018-2023 (K Units)
Figure 34. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue 2018-2023 ($ Millions)
Figure 37. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country in 2022
Figure 38. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country in 2022
Figure 39. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2018-2023)
Figure 40. Americas Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2018-2023)
Figure 41. United States Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Region in 2022
Figure 46. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Regions in 2022
Figure 47. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2018-2023)
Figure 48. APAC Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2018-2023)
Figure 49. China Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country in 2022
Figure 57. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country in 2022
Figure 58. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2018-2023)
Figure 59. Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2018-2023)
Figure 60. Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share by Application (2018-2023)
Figure 69. Egypt Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices in 2022
Figure 75. Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Figure 76. Industry Chain Structure of Benign Prostatic Hyperplasia (BPH) Treatment Devices
Figure 77. Channels of Distribution
Figure 78. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Forecast by Region (2024-2029)
Figure 79. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue Market Share Forecast by Application (2024-2029)

※参考情報

前立腺肥大症（BPH）は、男性の加齢に伴って前立腺が肥大し、尿道を圧迫することにより様々な尿路症状を引き起こす疾患です。このタイプの健康問題は特に高齢者に多く見られ、日常生活に大きな影響を与えることがあります。本稿では、前立腺肥大症の治療装置に関する概念について、定義、特徴、種類、用途、関連技術を中心に説明いたします。

まず、前立腺肥大症とは、主に前立腺の組織が非癌性に拡大する状態を指します。この疾患は、排尿が困難になる、頻尿、残尿感などの症状を引き起こします。これらの症状は、患者の生活の質を低下させ、場合によっては合併症を引き起こすこともあります。そのため、効果的な治療法が求められています。

前立腺肥大症の治療法は主に薬物療法と外科的療法に分類されますが、近年では治療装置による新しいアプローチも注目を浴びています。特に、非侵襲的または最小侵襲の治療装置が開発され、患者にとって負担の少ない方法として期待されています。

前立腺肥大症の治療装置にはいくつかの特徴があります。一つは、従来の手術に比べて痛みや出血が少なく、患者の回復時間も短いことです。また、多くの治療装置は、入院を必要とせず、日帰りで手術が可能なものもあります。これにより、患者は精神的にも肉体的にも負担が軽減されます。

種類としては、まずレーザー治療装置があります。レーザーを使用して前立腺組織を蒸発させることにより、尿道の通過を改善する方法です。次に、超音波治療装置もあります。高強度焦点超音波（HIFU）を利用し、前立腺組織を選択的に破壊する技術です。これにより、周囲の組織に対する損傷を最小限に抑えることができます。

また、電気的な治療装置も存在します。電気によって組織を切除または凝固させる方法で、尿道を広げるのに役立ちます。さらに、最近ではバルーン拡張術に関連する装置も開発されています。これらは尿道を物理的に拡張し、症状を改善することを目的としている装置です。

これらの治療装置の用途としては、BPHの症状を軽減することが挙げられます。また、従来の治療法が効かない場合や、副作用が懸念される患者に対しても効果を発揮することが期待されています。治療装置は、特に初期の段階での症状改善に寄与することが多く、患者の生活の質を向上させる手助けとなります。

さらに、これらの治療装置は、関連技術との統合によりその効果を高めています。たとえば、人工知能（AI）を用いた診断支援技術が開発され、患者の症状に応じた最適な治療法を選択するプロセスが進化しています。これにより、治療の精度が向上し、より個別化された医療が可能となるのです。

結論として、前立腺肥大症の治療装置は、患者にとっての負担を軽減し、効果的な症状改善を提供する新しい選択肢となっています。技術の進歩とともに、さらなる改善が期待され、今後の研究により禍福が大いに進展することでしょう。このような装置の普及が進むことで、前立腺肥大症の患者がより良い生活を送る手助けとなることを願ってやみません。


★調査レポート[世界の前立腺肥大症（BPH）治療装置市場予測 2023年-2029年] (コード：LP23MY4158)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の前立腺肥大症（BPH）治療装置市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の前立腺肥大症（BPH）治療市場予測2023年-2028年

    • ◆H&Iグローバルリサーチのお客様（例）◆